Sushil Patel
Director/Board Member chez REVOLUTION MEDICINES, INC.
Fortune : 320 520 $ au 29/02/2024
Profil
Sushil Patel is on the board of Revolution Medicines, Inc. and Chief Strategy Officer at Replimune Group, Inc.
In his past career Dr. Patel was Vice President-Franchise & Head-Oncology at Genentech, Inc.
He received a graduate degree from Imperial College London, a doctorate from the University of London and an undergraduate degree from the University of Warwick.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
REPLIMUNE GROUP, INC.
0,04% | 30/06/2023 | 25 331 ( 0,04% ) | 217 340 $ | 29/02/2024 |
26/09/2023 | 3 500 ( 0,00% ) | 103 180 $ | 29/02/2024 |
Postes actifs de Sushil Patel
Sociétés | Poste | Début |
---|---|---|
REPLIMUNE GROUP, INC. | Corporate Officer/Principal | 03/01/2023 |
REVOLUTION MEDICINES, INC. | Director/Board Member | 16/06/2022 |
Anciens postes connus de Sushil Patel
Sociétés | Poste | Fin |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2021 |
Formation de Sushil Patel
Imperial College London | Graduate Degree |
University of London | Doctorate Degree |
University of Warwick | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
REVOLUTION MEDICINES, INC. | Health Technology |
REPLIMUNE GROUP, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |